What We Do

Prepare for lasting clinical and commercial success with our Portfolio, Licensing & Development strategies. Science-based, future-focused, and comprehensive, we provide sound guidance for your most critical clinical development, opportunity prioritization, and go/no-go decisions.

Maximize the Asset Value of Your Products

Take your life-changing innovations further. See how our Portfolio, Licensing & Development strategies can help you develop bold clinical and commercial strategies that maximize the value and human impact of your products.

Optimize Your Portfolio Mix

Is your pipeline set up for lasting success? Build and optimize your portfolio mix with our science-based and future-focused Portfolio, Licensing & Development strategies.

Ensure Sustainable, Long-Term Success

A full pipeline doesn’t guarantee long-term success. See how our Portfolio, Licensing & Development strategies can help you position your early-stage assets and platforms for the future landscape.

How We Help

Learn the current treatment paradigm and residual unmet needs. Discover future standards of care and emerging patient segments. Understand the patient journey and key stakeholder challenges.

 

Learn how these strategies can work for you. Get more information.

Prioritize indications and shortlist targets for emerging technologies, based on speed-to-market, ease of technical development, and commercial attractiveness.

 

Learn how these strategies can work for you. Get more information.

Uncover the business case, roadmap, and/or indication sequencing for go/no-go clinical investment decisions.

 

Learn how these strategies can work for you. Get more information.

Determine the optimal portfolio mix required for clinical and commercial success aligned to your organization’s strategic and financial goals and risk threshold.

 

Learn how these strategies can work for you. Get more information.

Discover the clinical and health-economic evidence that must be generated to maximize adoption and establish sustainable clinical differentiation for your regimen.

 

Learn how these strategies can work for you. Get more information.

Learn the unique risks, drivers, and barriers to consider for your novel platform or target and establish a strategy to mitigate risk.

 

Learn how these strategies can work for you. Get more information.

Learn how to characterize site archetypes, identify centers of excellence, determine the optimal site mix, and activate sites at the institution and stakeholder levels.

 

Learn how these strategies can work for you. Get more information.

Case Studies

The Challenge

With several other in-class competitors, a client sought Putnam’s guidance on a go/no-go development decision for a first-generation targeted therapy in Phase 1 clinical development.

Our Solution

We worked to understand its projected value proposition and commercial viability by assessing the competitive landscape and development approaches, prioritizing opportunities, developing target profiles and value propositions, validating with KOLs, and using base- and best-case assumptions.

The Results

We provided the revenue potential of the asset by scenario for visibility on what revenue gaps the asset could fill over a period of time, leading to the client’s go/no-go decision for the early asset.

The Challenge

A clinical-stage biopharmaceutical company sought to develop an optimized portfolio strategy. It sought Putnam’s guidance to prioritize asset-level strategies through a holistic review of options.

Our Solution

We generated a comprehensive list of asset opportunities and portfolio options and prioritized 18 programs by applying pre-agreed criteria, defining the value of each opportunity, creating revenue streams with market criteria, and facilitating working sessions to align on critical assumptions.

The Results

Our portfolio recommendations addressed the enterprise goals of being best-in-class, maximizing economic value, achieving optimal timing, and minimizing risk over time and across geographies.

Meet Some of Our Experts

John L’Ecuyer

Executive Director of Global Business Development

LinkedIn

Joanna Rys, PhD

Partner

LinkedIn

Joseph Feingold, PhD

Partner
Portfolio, Licensing, and Development Practice Lead, and Head of Advanced Technologies Center of Excellence

LinkedIn

Vikram Gosain

Partner

LinkedIn

Get More Information!

Let us help you build and optimize your product and portfolio. Get in touch.
  • This field is for validation purposes and should be left unchanged.

Strategy for the Life Sciences